Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil.

Saved in:
Bibliographic Details
Title: Cost-Minimization Analysis of Bevacizumab Verse Cetuximab in First-Line Treatment for Metastatic Colorectal Cancer in Kras Wild-Type Patients in the Supplementary Health Care System in Brazil.
Authors: Tsuchiya CT; Roche Brazil, São Paulo, Brazil., Kim HS; Roche Brazil, São Paulo, Brazil., Maximo MF; Roche Brazil, São Paulo, Brazil., Ramos LA; Roche Brazil, São Paulo, Brazil.
Source: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2014 Nov; Vol. 17 (7), pp. A641. Date of Electronic Publication: 2014 Oct 26.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1524-4733
DOI:10.1016/j.jval.2014.08.2311